|
Squalamine For Wet AMD And Ohr Pharmaceuticals: Pluses And Minuses
Seeking Alpha Squalamine for wet AMD is Ohr Pharmaceutical’s leading candidate with phase 2 enrolment completed and results pending. Squalamine has strengths and weaknesses as a pipeline candidate. Strengths are that if approved, it will be much cheaper than … Ohr closes patient enrollment in Phase II trial of wet–AMD treatment SqualaminePharmaceutical Business Review |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.